IN

Inga Nazarenko

Director, Medical Strategy at EVERSANA Intouch Solutions

Inga Nazarenko has a diverse background in the medical field, spanning over two decades. Inga is currently working as a Senior Medical Director at EVERSANA INTOUCH since 2023. Prior to this, Inga held positions at various organizations such as Intouch Solutions, where they worked as a Director of Medical Strategy starting in July 2021, and Ogilvy Health, where they served as an Associate Medical Director from January 2017 to October 2019.

Inga's experience also includes research roles at renowned institutions like Memorial Sloan Kettering Cancer Center, where they worked as a Postdoctoral Research Fellow from June 2015 to December 2016. Before that, they were a Postdoctoral Research Fellow at UT Southwestern from June 2012 to May 2015, where they also held leadership roles in the Postdoctoral Association.

Inga's academic journey started at the University of Tartu, where they pursued their B.S. degree in a program from September 1997 to August 2002. Inga then went on to complete their Ph.D. at Karolinska Institutet, where they started as a PhD student in 2003 and continued until 2011. In addition, Inga worked as a Visiting Research Scientist at Uppsala University from September 2001 to January 2002.

Their career began as a Laboratory Assistant at Quattromed, a medical diagnostics company, from January 2001 to June 2001. In summary, Inga has a strong background in medical research, strategy development, and leadership, making their a valuable asset to any organization in the healthcare industry.

Inga Nazarenko's education history begins in 1997 at the University of Tartu, where they pursued a Bachelor's degree in Molecular Biology and Genetics. Inga completed their studies in 2002. From 2001 to 2002, they also attended Uppsala University, where they engaged in a specific part of their Bachelor's degree studies focusing on Developmental Biology and Embryology. In 2003, Inga enrolled at Karolinska Institutet, where they obtained their PhD in Experimental Pathology/Oncology in the field of Medical Science, completing their degree in 2011.

Links

Peers

View in org chart

Timeline

  • Director, Medical Strategy

    July, 2021 - present

  • Associate Director Medical Strategy

    October, 2019